The Predictive Role of HPV Integration in HSIL and Cervical Cancer

Tongji Hospital

Status: Unknown

Conditions: HPV Integration

Treatments: Diagnostic Test: HPV integration test

Study type: Observational

Funder types: Other

Identifiers

NCT05300243

2021-S140

Details and patient eligibility

About

The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.

Enrollment: 1 estimated patient

Sex: Female

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• HPV-positive patients； Patients have completed HPV detection, TCT, and HPV integration detection before surgery or biopsy； Patients with priced diagnoses accepted treatment according to ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors； Patients who are voluntary participants in this research and cooperate to follow-up with subscribing informed consent.

Exclusion criteria

• Patients who are not suitable for the trial； Patients existing other subtype malignancy tumors are still in treatment.